ATE419852T1 - Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben - Google Patents

Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben

Info

Publication number
ATE419852T1
ATE419852T1 AT03758540T AT03758540T ATE419852T1 AT E419852 T1 ATE419852 T1 AT E419852T1 AT 03758540 T AT03758540 T AT 03758540T AT 03758540 T AT03758540 T AT 03758540T AT E419852 T1 ATE419852 T1 AT E419852T1
Authority
AT
Austria
Prior art keywords
treatment
nasopharyngal
carcinomas
preparation
drug combination
Prior art date
Application number
AT03758540T
Other languages
English (en)
Inventor
Gregoire Prevost
Pierre Busson
Jean-Michel Vicat
Original Assignee
Sod Conseils Rech Applic
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic, Centre Nat Rech Scient filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE419852T1 publication Critical patent/ATE419852T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT03758540T 2002-09-27 2003-09-29 Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben ATE419852T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41410302P 2002-09-27 2002-09-27

Publications (1)

Publication Number Publication Date
ATE419852T1 true ATE419852T1 (de) 2009-01-15

Family

ID=32043348

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03758540T ATE419852T1 (de) 2002-09-27 2003-09-29 Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben

Country Status (8)

Country Link
US (2) US20060166907A1 (de)
EP (1) EP1542691B1 (de)
JP (1) JP2006500421A (de)
AT (1) ATE419852T1 (de)
AU (1) AU2003274565A1 (de)
DE (1) DE60325744D1 (de)
ES (1) ES2316811T3 (de)
WO (1) WO2004028541A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60325744D1 (de) * 2002-09-27 2009-02-26 Sod Conseils Rech Applic Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben
WO2005089515A2 (en) * 2004-03-18 2005-09-29 The Brigham And Women's Hospital, Inc. Methods for the treatment of synucleinopathies
EP1928237A4 (de) 2005-09-02 2011-03-09 Abbott Lab Neue heterocyclen auf imidazo-basis
US8232402B2 (en) 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
NZ593090A (en) 2008-11-13 2013-06-28 Link Medicine Corp Azaquinolinone derivatives and uses thereof
UY32776A (es) 2009-07-09 2011-02-28 Irm Llc Compuestos de imidazopirazinas sustituidas para el tratamiento de enfermedades parasitarias,composiciones farmacéuticas que los contienen y aplicación.
CN110691597A (zh) 2017-04-24 2020-01-14 诺华股份有限公司 2-氨基-1-(2-(4-氟苯基)-3-(4-氟苯基氨基)-8,8-二甲基-5,6-二氢咪唑并[1,2-a]吡嗪-7(8H)-基)乙酮及其组合的治疗方案

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673927B2 (en) * 1996-02-16 2004-01-06 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Farnesyl transferase inhibitors
EP1140942B1 (de) * 1998-12-31 2004-03-10 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Prenyltransferase-inhibitoren
WO2001064197A2 (en) * 2000-02-29 2001-09-07 Janssen Pharmaceutica N.V. Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
DE60325744D1 (de) * 2002-09-27 2009-02-26 Sod Conseils Rech Applic Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben

Also Published As

Publication number Publication date
EP1542691B1 (de) 2009-01-07
AU2003274565A8 (en) 2004-04-19
US20080161253A1 (en) 2008-07-03
EP1542691A2 (de) 2005-06-22
AU2003274565A1 (en) 2004-04-19
ES2316811T3 (es) 2009-04-16
US20060166907A1 (en) 2006-07-27
DE60325744D1 (de) 2009-02-26
WO2004028541A3 (en) 2004-07-01
WO2004028541A2 (en) 2004-04-08
JP2006500421A (ja) 2006-01-05

Similar Documents

Publication Publication Date Title
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
ATE408601T1 (de) Fredericamycin-derivate
ATE409189T1 (de) Farnesyl transferase-hemmende 6- heterocyclylmethyl-chinolin und chinazol-derivate
NO20034056L (no) Kombinasjoner av epotilonanaloger og kjemoterapeutiske midler for behandling av proliferative sykdommer
MXPA03010909A (es) Derivados de epotilona.
SE0102315D0 (sv) Compounds
SE0203752D0 (sv) New compounds
CY1106829T1 (el) Νεα σπιροτρικυκλικα παραγωγα και η χρηση τους ως αναστολεων φωσφοδιεστερασης-7
DE60118544D1 (de) Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
AR025020A1 (es) Forma de administracion oral que contiene al menos una especie de microorganismos probioticos, y procedimiento para su preparacion
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
ATE273699T1 (de) Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
DE60040213D1 (de) Tumorimpfstoff
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
ATE419852T1 (de) Zubereitung zur behandlung des nasopharyngalen carcinom und verwendung derselben
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
HUP0101947A2 (hu) Tumorok kezelésére szolgáló kombinációs készítmény
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
DE60305279D1 (de) Verwendung von Methyltestosteron zur Behandlung von menschlichen Papillomavirus Infektionen
MXPA04000272A (es) Derivados de 4-aminociclohexanol sustituidos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties